These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
    Author: Chungh DS, Kim BN, Cho SC.
    Journal: J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999.
    Abstract:
    Neuroleptic Malignant Syndrome (NMS) is a rare, potentially fatal and idiosyncratic drug reaction. It is characterized by a sudden loss of body temperature control, renal and respiratory failure, muscle rigidity, loss of consciousness and impairment of autonomic nervous system. Although NMS was previously associated with the use of classical high-potency neuroleptics, cases have started to emerge with atypical neuroleptics. This article discusses the first case of NMS in a child, induced by the use of risperidone, olanzapine and quetiapine.
    [Abstract] [Full Text] [Related] [New Search]